Skip to main content
. 2014 Jul 10;9:3313–3324. doi: 10.2147/IJN.S62793

Figure 3.

Figure 3

Safety evaluation of HRA nanoparticles.

Notes: Hemolysis as a function of vehicle concentration of HRA conjugate and GA-HRA (n=3) (A); pathological section of vessel tissues (B); control (5% glucose solution) (a); combination of GA-ATRA-HA solution (b); HRA conjugate (c); GA-HRA (d).

Abbreviations: ATRA, all-trans retinoic acid; GA, gambogic acid; GA-HRA, GA-loaded HRA nanoparticles; HA, hyaluronic acid; HRA, hyaluronic acid-g-all-trans retinoic acid.